Ester Orlandi, Nicola Alessandro Iacovelli, Rossana Ingargiola, Carlo Resteghini, Paolo Bossi, Lisa Licitra, Marco Ferrari, Piero Nicolai
Malignancies of the anterior skull base are rare and recur in 40-80% of treated cases, varying with substantial variance according to histology, stage at primary diagnosis, and other factors. Most recurrences manifest within 2-5 years after primary treatment, but some histologies can relapse even decades after the first presentation. Management of recurrent anterior skull base tumors is challenging and a wide variety of treatment options are available. Similar to the primary setting, surgery is the mainstay of treatment...
2020: Advances in Oto-rhino-laryngology